CAS 438-67-5|Estrone sulfate sodium
| Common Name | Estrone sulfate sodium | ||
|---|---|---|---|
| CAS Number | 438-67-5 | Molecular Weight | 372.41 |
| Density | 1.349 g/cm3 | Boiling Point | / |
| Molecular Formula | C18H21NaO5S | Melting Point | 258-260°C |
| MSDS | ChineseUSA | Flash Point | / |
| Symbol | GHS07, GHS08 | Signal Word | Danger |
Names
| Name | estrone sodium sulfate |
|---|---|
| Synonym | More Synonyms |
Estrone sulfate sodium BiologicalActivity
| Description | Estrone sulfate, a biologically inactive form of estrogen, is a major circulating plasma estrogen that is converted into the biologically active estrogen, estrone (E1) by steroid sulfatase (STS). strone sulfate can be used for the research of breast cancer[1][2]. |
|---|---|
| Related Catalog | Signaling Pathways >>Others >>Estrogen Receptor/ERRResearch Areas >>Cancer |
| Target | Human Endogenous Metabolite |
| In Vitro | T47D cells are stably transfected with SOAT and incubated under increasing concentrations of Estrone sulfate and estradiol at physiologically relevant concentrations. Cell proliferation is significantly increased by 1 nM estradiol as well as by Estrone sulfate with EC50 of 2.2 nM[3]. |
| References | [1]. Nakamura Y, et al. Steroid sulfatase and estrogen sulfotransferase in the atherosclerotic human aorta. Am J Pathol. 2003;163(4):1329-1339. [2]. Duncan L, et al. Inhibition of estrone sulfatase activity by estrone-3-methylthiophosphonate: a potential therapeutic agent in breast cancer. Cancer Res. 1993;53(2):298-303. [3]. Karakus E, et al. Estrone-3-Sulfate Stimulates the Proliferation of T47D Breast Cancer Cells Stably Transfected With the Sodium-Dependent Organic Anion Transporter SOAT (SLC10A6). Front Pharmacol. 2018;9:941. Published 2018 Aug 21. |
Chemical & Physical Properties
| Density | 1.349 g/cm3 |
|---|---|
| Melting Point | 258-260°C |
| Molecular Formula | C18H21NaO5S |
| Molecular Weight | 372.41 |
| Exact Mass | 372.100739 |
| PSA | 91.88000 |
| LogP | 4.03160 |
| InChIKey | VUCAHVBMSFIGAI-ZFINNJDLSA-M |
| SMILES | CC12CCC3c4ccc(OS(=O)(=O)[O-])cc4CCC3C1CCC2=O.[Na+] |
| Storage condition | -20°C |
Toxicological Information
CHEMICAL IDENTIFICATION |
ACUTE TOXICITY DATA - TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Subcutaneous
- DOSE :
- 504 ug/kg
- SEX/DURATION :
- female 9 day(s) pre-mating
- TOXIC EFFECTS :
- Reproductive - Maternal Effects - menstrual cycle changes or disorders
- REFERENCE :
- JRPFA4 Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- Volume(issue)/page/year: 55,191,1979
Safety Information
| Symbol | GHS07, GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H315-H319-H335-H350 |
| Precautionary Statements | P201-P261-P305 + P351 + P338-P308 + P313 |
| Hazard Codes | T: Toxic; |
| Risk Phrases | R45-36/37/38 |
| Safety Phrases | S53-45-26 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | KG8775000 |
Articles30
More Articles| Major active components in grapefruit, orange, and apple juices responsible for OATP2B1-mediated drug interactions. J. Pharm. Sci. 102(1) , 280-8, (2013) We aimed to explore the major active components in grapefruit juice (GFJ), orange juice (OJ), and apple juice (AJ) that are responsible for OATP2B1-mediated drug interactions, by means of in vitro stu... | |
| Quantitative transporter proteomics by liquid chromatography with tandem mass spectrometry: addressing methodologic issues of plasma membrane isolation and expression-activity relationship. Drug Metab. Dispos. 43(2) , 284-8, (2015) To predict transporter-mediated drug disposition using physiologically based pharmacokinetic models, one approach is to measure transport activity and relate it to protein expression levels in cell li... | |
| Inclusion of endogenous hormone levels in risk prediction models of postmenopausal breast cancer. J. Clin. Oncol. 32(28) , 3111-7, (2014) Endogenous hormones are risk factors for postmenopausal breast cancer, and their measurement may improve our ability to identify high-risk women. Therefore, we evaluated whether inclusion of plasma es... |
Synonyms
| Estra-1(10),2,4-trien-17-one, 3-(sulfooxy)-, sodium salt (1:1) |
| Sodium 17-oxoestra-1(10),2,4-trien-3-yl sulfate |
| Estrone 3-sulfate sodium salt |
| Estrone sodium sulfate |
| Estrone sulfate sodium |
| Estrone-3-sulfate sodium salt |
| estrone sodium sulphate |
| Sodium estrone 3-sulfate |
